{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:39:55Z","timestamp":1790739595836,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T00:00:00Z","timestamp":1470960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T00:00:00Z","timestamp":1470960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer Journal"],"DOI":"10.1038\/bcj.2016.67","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T13:23:02Z","timestamp":1471008182000},"page":"e457-e457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Low natural killer (NK) cell counts in peripheral blood adversely affect clinical outcome of patients with follicular lymphoma"],"prefix":"10.1038","volume":"6","author":[{"given":"L","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-Y","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S-C","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-H","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y-J","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-Y","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,12]]},"reference":[{"key":"BFbcj201667_CR1","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","volume":"104","author":"P Solal-C\u00e9ligny","year":"2004","unstructured":"Solal-C\u00e9ligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R et al. Follicular lymphoma international prognostic index. Blood 2004; 104: 1258\u20131265.","journal-title":"Blood"},{"key":"BFbcj201667_CR2","doi-asserted-by":"publisher","first-page":"4555","DOI":"10.1200\/JCO.2008.21.3991","volume":"27","author":"M Federico","year":"2009","unstructured":"Federico M, Bellei M, Marcheselli L, Luminari S, Lopez-Guillermo A, Vitolo U et al. Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project. J Clin Oncol 2009; 27: 4555\u20134562.","journal-title":"J Clin Oncol"},{"key":"BFbcj201667_CR3","doi-asserted-by":"publisher","first-page":"513702","DOI":"10.1155\/2012\/513702","volume":"2012","author":"JM McDaniel","year":"2012","unstructured":"McDaniel JM, Pinilla-Ibarz J, Epling-Burnette PK . Molecular action of lenalidomide in lymphocytes and hematologic malignancies. Adv Hematol 2012; 2012: 513702.","journal-title":"Adv Hematol"},{"key":"BFbcj201667_CR4","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1093\/annonc\/mdm110","volume":"18","author":"A Plonquet","year":"2007","unstructured":"Plonquet A, Haioun C, Jais JP, Debard AL, Salles G, Bene MC et al. Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphoma. Ann Oncol 2007; 18: 1209\u20131215.","journal-title":"Ann Oncol"},{"key":"BFbcj201667_CR5","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.leukres.2013.07.038","volume":"37","author":"D Shafer","year":"2013","unstructured":"Shafer D, Smith MR, Borghaei H, Millenson MM, Li T, Litwin S et al. Low NK cell counts in peripheral blood are associated with inferior overall survival in patients with follicular lymphoma. Leuk Res 2013; 37: 1213\u20131215.","journal-title":"Leuk Res"},{"key":"BFbcj201667_CR6","doi-asserted-by":"publisher","first-page":"8200","DOI":"10.1073\/pnas.92.18.8200","volume":"92","author":"JL Schultze","year":"1995","unstructured":"Schultze JL, Cardoso AA, Freeman GJ, Seamon MJ, Daley J, Pinkus GS et al. Follicular lymphomas can be induced to present alloantigen efficiently: A conceptual model to improve their tumor immunogenicity. Proc Natl Acad Sci USA 1995; 92: 8200\u20138204.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFbcj201667_CR7","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.4049\/jimmunol.172.3.1455","volume":"172","author":"G Ferlazzo","year":"2004","unstructured":"Ferlazzo G, Thomas D, Lin SL . The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 2004; 172: 1455\u20131462.","journal-title":"J Immunol"},{"key":"BFbcj201667_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/sj.emboj.7600019","volume":"23","author":"L Moretta","year":"2004","unstructured":"Moretta L, Moretta A . Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J 2004; 23: 255\u2013259.","journal-title":"EMBO J"},{"key":"BFbcj201667_CR9","doi-asserted-by":"publisher","first-page":"803","DOI":"10.2165\/00003495-200363080-00005","volume":"63","author":"GL Plosker","year":"2003","unstructured":"Plosker GL, Figgitt DP . Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs 2003; 63: 803\u2013843.","journal-title":"Drugs"},{"key":"BFbcj201667_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1053\/j.seminhematol.2010.01.011","volume":"47","author":"GJ Weiner","year":"2010","unstructured":"Weiner GJ . Rituximab: mechanism of action. Semin Hematol 2010; 47: 115\u2013123.","journal-title":"Semin Hematol"},{"key":"BFbcj201667_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5045\/br.2014.49.3.162","volume":"49","author":"JK Kim","year":"2014","unstructured":"Kim JK, Chung JS, Shin HJ, Song MK, Yi JW, Shin DH et al. Influence of NK cell count on the survival of patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood Res 2014; 49: 162\u2013169.","journal-title":"Blood Res"},{"key":"BFbcj201667_CR12","doi-asserted-by":"publisher","first-page":"5404","DOI":"10.1200\/JCO.2008.21.1169","volume":"27","author":"TE Witzig","year":"2009","unstructured":"Witzig TE, Wiernik PH, Moore T, Reeder C, Cole C, Justice G et al. Lenalidomide oral monotherapy produces durable responses in relapsed or refractory indolent non-Hodgkin's Lymphoma. J Clin Oncol 2009; 27: 5404\u20135409.","journal-title":"J Clin Oncol"},{"key":"BFbcj201667_CR13","doi-asserted-by":"publisher","first-page":"4650","DOI":"10.1158\/1078-0432.CCR-07-4405","volume":"14","author":"L Wu","year":"2008","unstructured":"Wu L, Adams M, Carter T, Chen R, Muller G, Stirling D et al. Lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells. Clin Cancer Res 2008; 14: 4650\u20134657.","journal-title":"Clin Cancer Res"},{"key":"BFbcj201667_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1089\/15258160152509145","volume":"10","author":"T Tonn","year":"2001","unstructured":"Tonn T, Becker S, Esser R, Schwabe D, Seifried E . Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92. J Hematother Stem Cell Res 2001; 10: 535\u2013544.","journal-title":"J Hematother Stem Cell Res"},{"key":"BFbcj201667_CR15","first-page":"2859","volume":"4","author":"Y Yan","year":"1998","unstructured":"Yan Y, Steinherz P, Klingemann HG, Dennig D, Childs BH, McGuirk J et al. Antileukemia activity of a natural killer cell line against human leukemias. Clin Cancer Res 1998; 4: 2859\u20132868.","journal-title":"Clin Cancer Res"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bcj201667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201667","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bcj201667.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T08:50:47Z","timestamp":1672822247000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bcj201667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,12]]},"references-count":15,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8]]}},"alternative-id":["BFbcj201667"],"URL":"https:\/\/doi.org\/10.1038\/bcj.2016.67","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,12]]},"assertion":[{"value":"12 August 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}